67 related articles for article (PubMed ID: 22370791)
1. The influence of stabilizer and bioadhesive polymer on the permeation-enhancing effect of AT1002 in the nasal delivery of a paracellular marker.
Song KH; Eddington ND
Arch Pharm Res; 2012 Feb; 35(2):359-66. PubMed ID: 22370791
[TBL] [Abstract][Full Text] [Related]
2. The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan.
Song KH; Eddington ND
Arch Pharm Res; 2012 May; 35(5):937-43. PubMed ID: 22644862
[TBL] [Abstract][Full Text] [Related]
3. Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery.
Song KH; Kim SB; Shim CK; Chung SJ; Kim DD; Rhee SK; Choi GJ; Kim CH; Kim K
Drug Des Devel Ther; 2015; 9():1815-23. PubMed ID: 25848218
[TBL] [Abstract][Full Text] [Related]
4. The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.
Song KH; Eddington ND
J Pharm Pharmacol; 2012 Jan; 64(1):30-9. PubMed ID: 22150669
[TBL] [Abstract][Full Text] [Related]
5. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
Song KH; Fasano A; Eddington ND
Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
[TBL] [Abstract][Full Text] [Related]
6. Enhanced nasal absorption of hydrophilic markers after dosing with AT1002, a tight junction modulator.
Song KH; Fasano A; Eddington ND
Eur J Pharm Biopharm; 2008 May; 69(1):231-7. PubMed ID: 18039562
[TBL] [Abstract][Full Text] [Related]
7. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
Motlekar NA; Fasano A; Wachtel MS; Youan BB
J Drug Target; 2006 Jun; 14(5):321-9. PubMed ID: 16882552
[TBL] [Abstract][Full Text] [Related]
8. Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol.
Salama NN; Fasano A; Lu R; Eddington ND
Int J Pharm; 2003 Jan; 251(1-2):113-21. PubMed ID: 12527181
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002.
Uchida T; Kanazawa T; Kawai M; Takashima Y; Okada H
J Pharmacol Exp Ther; 2011 Aug; 338(2):443-50. PubMed ID: 21531792
[TBL] [Abstract][Full Text] [Related]
10. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
[TBL] [Abstract][Full Text] [Related]
11. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
Kamei N; Morishita M; Ehara J; Takayama K
J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery.
Figueiras A; Hombach J; Veiga F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2009 Feb; 71(2):339-45. PubMed ID: 18796330
[TBL] [Abstract][Full Text] [Related]
13. Oligoarginine-linked polymers as a new class of penetration enhancers.
Sakuma S; Suita M; Masaoka Y; Kataoka M; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Yamashita S
J Control Release; 2010 Dec; 148(2):187-96. PubMed ID: 20800631
[TBL] [Abstract][Full Text] [Related]
14. Permeation enhancers in the transmucosal delivery of macromolecules.
Sharma S; Kulkarni J; Pawar AP
Pharmazie; 2006 Jun; 61(6):495-504. PubMed ID: 16826967
[TBL] [Abstract][Full Text] [Related]
15. Enhanced local anesthetic action of mepivacaine from the bioadhesive gels.
Cho CW; Choi JS; Shin SC
Pak J Pharm Sci; 2011 Jan; 24(1):87-93. PubMed ID: 21190925
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
Charlton ST; Davis SS; Illum L
J Control Release; 2007 Apr; 118(2):225-34. PubMed ID: 17261340
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits.
Al-Ghananeem AM; Malkawi AH; Crooks PA
Drug Dev Ind Pharm; 2011 Mar; 37(3):329-34. PubMed ID: 21244195
[TBL] [Abstract][Full Text] [Related]
18. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
19. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
20. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
Uchida T; Kanazawa T; Takashima Y; Okada H
Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
